CIK 0001799011 · <br>Emerging growth company
Lucid Diagnostics Inc.
Sign in to watch- Ticker
- LUCD
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825488042
- Phone
- 212 949 4319
- Business address
- 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | PAVmed Inc. 10% owner | Other disposition | −3,331,747 | 31,302,444 | ||
| 2024-01-26 | PAVmed Inc. 10% owner | Other acquisition | +3,331,771 | $1.40 | $4.7M | 34,634,191 |
| 2023-09-26 | Lapidus Stanley Director | Sale 10b5-1 | −10,000 | $1.47 | $15K | 121,339 |
| 2023-09-26 | Lapidus Stanley Director | Sale 10b5-1 | −10,000 | $1.43 | $14K | 111,339 |
| 2023-09-26 | Lapidus Stanley Director | Sale 10b5-1 | −9,747 | $1.45 | $14K | 101,592 |
| 2023-09-25 | Lapidus Stanley Director | Sale 10b5-1 | −200 | $1.43 | $286 | 131,339 |
| 2023-09-21 | Lapidus Stanley Director | Sale 10b5-1 | −100 | $1.44 | $144 | 131,539 |
| 2023-09-21 | Lapidus Stanley Director | Sale | −100 | $1.44 | $144 | 131,539 |
| 2023-09-20 | Lapidus Stanley Director | Sale 10b5-1 | −3,405 | $1.45 | $5K | 132,051 |
| 2023-09-20 | Lapidus Stanley Director | Sale 10b5-1 | −412 | $1.44 | $593 | 131,639 |
| 2023-09-20 | Lapidus Stanley Director | Sale | −3,405 | $1.45 | $5K | 132,051 |
| 2023-09-20 | Lapidus Stanley Director | Sale | −412 | $1.44 | $593 | 131,639 |
| 2023-01-31 | Sparks Ronald M Director | Grant or award · Employee stock option (right to buy) | +175,000 | 175,000 | ||
| 2023-01-31 | White Debra Director | Grant or award · Employee stock option (right to buy) | +175,000 | 175,000 | ||
| 2023-01-31 | SOKOLOV JACQUE J Director | Grant or award · Employee stock option (right to buy) | +175,000 | 175,000 | ||
| 2023-01-31 | Lapidus Stanley Director | Grant or award · Employee stock option (right to buy) | +175,000 | 175,000 | ||
| 2023-01-31 | Cox James L Director | Grant or award · Employee stock option (right to buy) | +175,000 | 175,000 | ||
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +1,145,086 | $1.84 | $2.1M | 29,072,276 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +197,656 | $2.78 | $550K | 29,269,932 |
| 2022-11-30 | PAVmed Inc. 10% owner | Other acquisition | +221,952 | $2.48 | $550K | 29,491,884 |
Page 3 of 5 · 82 trades